First-line therapy with palbociclib in patients with advanced HR(+)/HER2(-) breast cancer: The real-life study PALBOSPAIN. Martinez-Janez N, Ezquerra MB, Manso Sanchez LM, Carrasco FH, et al. Breast Cancer Res Treat 2024 Apr 1. doi: 10.1007/s10549-024-07287.

Read + Share

Amedeo Smart

Independent Medical Education

Martinez-Janez N, Ezquerra MB, Manso Sanchez LM, Carrasco FH, et al. First-line therapy with palbociclib in patients with advanced HR(+)/HER2(-) breast cancer: The real-life study PALBOSPAIN. Breast Cancer Res Treat 2024 Apr 1. doi: 10.1007/s10549-024-07287.
PMID: 38561577